• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析前和分析后变量:止血诊断错误的主要原因?

Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis?

作者信息

Favaloro Emmanuel J, Lippi Giuseppe, Adcock Dorothy M

机构信息

Department of Haematology, ICPMR, Westmead Hospital, Westmead, Australia.

出版信息

Semin Thromb Hemost. 2008 Oct;34(7):612-34. doi: 10.1055/s-0028-1104540. Epub 2008 Dec 15.

DOI:10.1055/s-0028-1104540
PMID:19085762
Abstract

The advent of modern instrumentation, with associated improvements in test reliability, together with appropriate internal quality control and external quality assurance measures, has led to substantial reduction in analytical errors within hemostasis laboratories. Unfortunately, the reporting of incorrect or inappropriate test results still occurs, perhaps even as frequently as in the past. Many of these cases will arise due to a variety of events largely outside the control of the laboratories performing the laboratory tests and primarily comprise preanalytical events related to patient collection and sample processing and postanalytical events related to the reporting and interpretation of test results. The current article provides an overview of these events and provides some suggestions on how they can be minimized or prevented to ensure that the test results the clinician receives actually represent the true clinical status of the patient under investigation rather than just reflecting the status of an (inappropriate) clinical sample received and tested. This article should be of interest to both laboratory scientists working in hemostasis and the clinicians that request such tests. The former, because these are ultimately responsible for the test results they provide to clinicians, and there is a duty of care to provide both accurate and precise results to enable clinicians to manage patients appropriately and to avoid the need to recollect and retest. The latter because unless clinicians gain an appreciation of these issues, they will not be in a position to best manage their patients.

摘要

现代检测仪器的出现,以及检测可靠性的相关提高,再加上适当的内部质量控制和外部质量保证措施,已使止血实验室的分析误差大幅减少。不幸的是,不正确或不恰当检测结果的报告仍时有发生,甚至可能与过去一样频繁。许多此类情况是由各种很大程度上超出进行实验室检测的实验室控制范围的事件引起的,主要包括与患者采血和样本处理相关的分析前事件以及与检测结果报告和解释相关的分析后事件。本文概述了这些事件,并就如何将其最小化或预防提供了一些建议,以确保临床医生收到的检测结果实际代表所调查患者的真实临床状况,而不仅仅反映所接收和检测的(不恰当)临床样本的状况。本文对于从事止血工作的实验室科学家和要求进行此类检测的临床医生都应具有参考价值。对于前者而言,因为他们最终要对向临床医生提供的检测结果负责,有责任提供准确和精确的结果,以使临床医生能够恰当地管理患者并避免重新采血和重新检测的需要。对于后者而言,因为除非临床医生了解这些问题,否则他们将无法最佳地管理患者。

相似文献

1
Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis?分析前和分析后变量:止血诊断错误的主要原因?
Semin Thromb Hemost. 2008 Oct;34(7):612-34. doi: 10.1055/s-0028-1104540. Epub 2008 Dec 15.
2
Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?实验室止血检测报告:减少止血诊断中分析后错误的最后机会?
Clin Chem Lab Med. 2010 Mar;48(3):309-21. doi: 10.1515/CCLM.2010.061.
3
Post-analytical Issues in Hemostasis and Thrombosis Testing.止血与血栓形成检测中的分析后问题
Methods Mol Biol. 2017;1646:545-559. doi: 10.1007/978-1-4939-7196-1_40.
4
Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors.外部质量保证计划的调查显示,凝血因子抑制剂的实验室鉴定存在高度变异性。
Semin Thromb Hemost. 2009 Nov;35(8):794-805. doi: 10.1055/s-0029-1245112. Epub 2010 Feb 18.
5
Preanalytical Issues in Hemostasis and Thrombosis Testing.止血与血栓形成检测中的分析前问题
Methods Mol Biol. 2017;1646:29-42. doi: 10.1007/978-1-4939-7196-1_2.
6
Patient safety and quality in laboratory and hemostasis testing: a renewed loop?实验室和止血检测中的患者安全和质量:一个新的循环?
Semin Thromb Hemost. 2012 Sep;38(6):553-8. doi: 10.1055/s-0032-1315960. Epub 2012 Jun 2.
7
Standardization, regulation, quality assurance and emerging technologies in hemostasis: issues, controversies, benefits, and limitations.止血领域的标准化、监管、质量保证及新兴技术:问题、争议、益处与局限
Semin Thromb Hemost. 2007 Apr;33(3):290-7. doi: 10.1055/s-2007-971816.
8
External quality assurance in thrombosis and hemostasis: an international perspective.血栓与止血的外部质量保证:国际视角
Semin Thromb Hemost. 2007 Apr;33(3):220-5. doi: 10.1055/s-2007-971207.
9
Quality standards for sample processing, transportation, and storage in hemostasis testing.止血检测中样本处理、运输和存储的质量标准。
Semin Thromb Hemost. 2012 Sep;38(6):576-85. doi: 10.1055/s-0032-1319768. Epub 2012 Jun 16.
10
Laboratory error undetectable by customary quality control/quality assurance monitors.常规质量控制/质量保证监测无法检测到的实验室误差。
Arch Pathol Lab Med. 1993 Jul;117(7):714-8.

引用本文的文献

1
Assessing the Reliability of D-Dimer Measurement in EDTA Plasma: A Comparison to the Established Citrate Method.评估乙二胺四乙酸(EDTA)血浆中D-二聚体检测的可靠性:与既定的柠檬酸盐法比较。
Diagnostics (Basel). 2025 Jul 6;15(13):1720. doi: 10.3390/diagnostics15131720.
2
Practical handling of hemolytic, icteric and lipemic samples for coagulation testing in European laboratories. A collaborative survey from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM).欧洲实验室中用于凝血检测的溶血、黄疸和脂血样本的实际处理。来自欧洲实验室医学外部质量保证提供者组织(EQALM)的一项合作调查。
Clin Chem Lab Med. 2025 May 22. doi: 10.1515/cclm-2025-0319.
3
Effects of storage time and temperature on coagulation factor and natural anticoagulant activities in healthy individuals.
储存时间和温度对健康个体凝血因子及天然抗凝活性的影响。
Sci Rep. 2025 Mar 28;15(1):10797. doi: 10.1038/s41598-025-95389-w.
4
Mitigating Lipemia Interference in Anti-Xa Activity Measurement Through High-Speed Centrifugation.通过高速离心减轻脂血对抗Xa活性测定的干扰。
Int J Lab Hematol. 2025 Apr;47(2):336-339. doi: 10.1111/ijlh.14393. Epub 2024 Oct 21.
5
Artificial intelligence in the pre-analytical phase: State-of-the art and future perspectives.分析前阶段的人工智能:现状与未来展望。
J Med Biochem. 2024 Jan 25;43(1):1-10. doi: 10.5937/jomb0-45936.
6
Platelets from blood diversion pouches (DPs) are a suitable alternative for functional, bioenergetic, and metabolomic analyses.来自血液分流袋(DPs)的血小板是进行功能、生物能量和代谢组学分析的合适替代物。
Blood Transfus. 2023 Mar 31;21(6):488-93. doi: 10.2450/BloodTransfus.519.
7
Post-analytical Issues in Hemostasis and Thrombosis Testing: An Update.止血和血栓形成检测的分析后问题:更新。
Methods Mol Biol. 2023;2663:787-811. doi: 10.1007/978-1-0716-3175-1_53.
8
Preanalytical Variables in Hemostasis Testing.止血检测的分析前变量。
Methods Mol Biol. 2023;2663:39-50. doi: 10.1007/978-1-0716-3175-1_2.
9
Evaluation of the Analytical Performances of the Biolabo SOLEA 100 Optical Coagulometer and Comparison with the Stago STA-R MAX Analyser in the Determination of PT, APTT, and Fibrinogen.评估Biolabo SOLEA 100光学凝血仪的分析性能,并与Stago STA-R MAX分析仪在测定凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)和纤维蛋白原方面进行比较。
Diagnostics (Basel). 2022 Dec 28;13(1):85. doi: 10.3390/diagnostics13010085.
10
Effect of anticoagulant adjustment on prothrombin time test using two different PT reagents in patients with elevated hematocrit.血细胞比容升高患者中使用两种不同凝血酶原时间试剂时抗凝调整对凝血酶原时间检测的影响
Pract Lab Med. 2020 Oct 17;22:e00177. doi: 10.1016/j.plabm.2020.e00177. eCollection 2020 Nov.